Based on FDA feedback, the use of a correlate of protection in an immunobridging approach to a pivotal EUA-directed clinical trial may be a reasonable approach for a new mAb candidate when clinical ...
Invivyd, Inc. advances VYD2311 as a Covid-19 vaccine alternative. Learn about upcoming trials and market opportunities. Click ...
The move would add another barrier for parents who want to vaccinate healthy children ahead of the respiratory virus season.
The American Academy of Family Physicians is urging the Food and Drug Administration to consider emergency use authorization of COVID-19 vaccines for children under the age of 12. Currently, vaccines ...
PEMGARDA® (pemivibart) net product revenue of $13.1 million reported for Q3 2025, representing 41% growth year-over-year and 11% growth ...
EUA to Treat Dogs for NWS Issued Prior to Fly Being Detected in the U.S.; Action Prepares Veterinarians and Pet Owners with Treatment Options First FDA emergency use authorization (EUA) ever granted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback